64 related articles for article (PubMed ID: 14017142)
1. The use of serum glycoprotein levels in the selection of patients with advanced breast cancer for endocrine surgery.
BURNETT W; McALLISTER RA; SHIELDS R
Scott Med J; 1963 May; 8():197-203. PubMed ID: 14017142
[No Abstract] [Full Text] [Related]
2. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
[TBL] [Abstract][Full Text] [Related]
3. Electrophoretic pattern of serum glycoproteins on polyacrylamide disc gel in patients with breast cancer.
Patel PS; Raval GN; Patel MM; Balar DB; Patel DD
Anticancer Res; 1996; 16(4A):2089-94. PubMed ID: 8712748
[TBL] [Abstract][Full Text] [Related]
4. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
[TBL] [Abstract][Full Text] [Related]
5. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
[TBL] [Abstract][Full Text] [Related]
6. A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.
Jerusalem G; Bachelot T; Barrios C; Neven P; Di Leo A; Janni W; de Boer R
Cancer Treat Rev; 2015 Feb; 41(2):94-104. PubMed ID: 25575443
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein synthesis as a function of epithelial cell arrangement: biosynthesis and release of glycoproteins by human breast and prostate cells in organ culture.
Tökés ZA; Dermer GB
J Supramol Struct; 1977; 7(3-4):515-30. PubMed ID: 211350
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of alpha 1-antichymotrypsin and alpha 1-acid glycoprotein by human breast epithelial cells.
Gendler SJ; Dermer GB; Silverman LM; Tökés ZA
Cancer Res; 1982 Nov; 42(11):4567-73. PubMed ID: 6290040
[TBL] [Abstract][Full Text] [Related]
9. Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
Carlsson MC; Balog CI; Kilsgård O; Hellmark T; Bakoush O; Segelmark M; Fernö M; Olsson H; Malmström J; Wuhrer M; Leffler H
Biochim Biophys Acta; 2012 Sep; 1820(9):1366-72. PubMed ID: 22285770
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.
Esposito G; Panza N; Mansi L; De Matteis A; D'Aiuto G; Labonia V; Riccardi F; Pacilio G; Salvatore M
J Nucl Med Allied Sci; 1990; 34(2):88-93. PubMed ID: 2246676
[TBL] [Abstract][Full Text] [Related]
11. CA-549: immunohistochemistry and serum levels in breast carcinoma and other neoplasms.
Shurbaji MS; Beveridge RA; Chan DW; Rock RC; Kuhajda FP
Ann Clin Lab Sci; 1989; 19(6):408-14. PubMed ID: 2481424
[TBL] [Abstract][Full Text] [Related]
12. Serum glycoproteins in inflammation and malignant diseases of female breast. Studies on the neutral glycoprotein fraction.
Torre GC; Salvatores D; Chisalè E
Cancro; 1970; 23(5):267-71. PubMed ID: 5535687
[No Abstract] [Full Text] [Related]
13. Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
Martinetti A; Bajetta E; Ferrari L; Zilembo N; Seregni E; Del Vecchio M; Longarini R; La Torre I; Toffolatti L; Paleari D; Bombardieri E
Endocr Relat Cancer; 2004 Dec; 11(4):771-9. PubMed ID: 15613451
[TBL] [Abstract][Full Text] [Related]
14. Serum proteins in breast cancer.
Alsabti EA; Muneir K
Jpn J Exp Med; 1979 Aug; 49(4):235-40. PubMed ID: 502079
[TBL] [Abstract][Full Text] [Related]
15. The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.
Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot AJ; van Tienoven DT; Beex LV; Sweep FC
Thromb Haemost; 2004 Mar; 91(3):514-21. PubMed ID: 14983227
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein-adsorption from cancer sera--influence on a mixed lymphocyte culture.
Richner J; Schuff-Werner P; Bätge R; Beyer JH; Nagel GA
J Clin Lab Immunol; 1985 Oct; 18(2):75-9. PubMed ID: 2934552
[TBL] [Abstract][Full Text] [Related]
17. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease.
Bremner RD; Nisbet AD; Herriot R; Horne CH; McArdle C; Crawford D; Bohn H
Oncodev Biol Med; 1981; 2(1-2):55-62. PubMed ID: 6975467
[TBL] [Abstract][Full Text] [Related]
18. The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy.
Koh EH; Chung HC; Lee KB; Lim HY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS
Yonsei Med J; 1992 Jun; 33(2):137-42. PubMed ID: 1357834
[TBL] [Abstract][Full Text] [Related]
19. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
20. Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.
Ju L; Wang Y; Xie Q; Xu X; Li Y; Chen Z; Li Y
Glycobiology; 2016 May; 26(5):460-71. PubMed ID: 26646445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
